Montelukast in hospitalized patients diagnosed with COVID-19

OBJECTIVE: Several therapeutic agents have been assessed for the treatment of COVID-19, but few approaches have been proven efficacious. Because leukotriene receptor antagonists, such as montelukast have been shown to reduce both cytokine release and lung inflammation in preclinical models of viral...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Asthma
Hlavní autoři: Khan, Ahsan R., Misdary, Christian, Yegya-Raman, Nikhil, Kim, Sinae, Narayanan, Navaneeth, Siddiqui, Sheraz, Salgame, Padmini, Radbel, Jared, Groote, Frank De, Michel, Carl, Mehnert, Janice, Hernandez, Caleb, Braciale, Thomas, Malhotra, Jyoti, Gentile, Michael A., Jabbour, Salma K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938648/
https://ncbi.nlm.nih.gov/pubmed/33577360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02770903.2021.1881967
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky